The goal of sarcoma surgery is a clean margin, meaning the tumor is removed along with a cuff of healthy tissue so that no cancer is left behind, and this outcome, known as an R0 resection, is one of the strongest predictors of whether the disease returns. It also turns out to depend heavily on who is holding the knife. In the nationwide reference-center data, specialist centers achieved a complete, clean removal in about 53% of cases, while non-specialist centers managed it in 19.6%, a roughly 2.7-fold difference in the odds of getting the whole tumor out cleanly on the first attempt.
That gap is not really about surgical talent in the general sense; it is about sarcoma-specific judgment, the kind built only by volume. A surgeon who resects these tumors regularly understands how they spread along tissue planes, how much margin to take, and how to plan the incision so that the operation is curative rather than merely removal, whereas a surgeon meeting a rare case for the first time is working largely without that instinct.
Why does a clean first margin matter so much? Because sarcoma is unforgiving about second chances. Cancer left behind at the edge is cancer that can regrow, seed the surrounding tissue, and force larger, riskier operations later, sometimes an amputation that a clean first surgery would have avoided altogether. The margin achieved on day one goes on shaping every day that follows.
This is the mechanism sitting underneath yesterday’s 32%, because better margins, achieved by teams that do this constantly, are a large part of why the address changes the odds at all. It is also why specialists are so insistent that sarcoma surgery be planned rather than improvised, and performed somewhere it is performed often. Fifty-three versus twenty is not a rounding difference; it is the difference between an operation that ends the problem and one that starts a longer one.